HAVANA, Jan. 28th Cuba’s Minister of Health, José Angel Portal Miranda, said that preliminary studies developed from the Pedro Kourí Institute of Tropical Medicine show that people vaccinated with Soberana and Abdala, the COVID-19 vaccines made by Cuba, have the ability to generate antibodies against Omicron.
According to the Ministry, high levels of neutralizing antibodies were observed in vaccinations with full doses of Abdala and Soberana 02. These levels increased with the application of the booster dose.
The Ministry said that this reconfirms the value of vaccination schemes, followed by booster reinforcements, which Cuba was administering before the emergence of the Omicron threat.
The statements were made around the same time that Cuba made it known that it will be presenting a dossier of its anti-Covid-19 vaccines to the World Health Organization (WHO) for certification.
“The process takes months and costs a lot. We have very valuable clinical data, of a first-level”, said the head of the IFV, the institution in charge of the Soberana 01, Soberana 02 and Soberana Plus vaccines.
In the meantime, reports state that Mexican health authorities gave the go-ahead for Abdala and there are authorizations for emergency use in Vietnam, Venezuela, Nicaragua, Saint Vincent and the Grenadines, with about 18 million doses having been exported to all these countries.
In addition, Soberana 02 and Soberana Plus have emergency use certifications for children in Iran, Venezuela and Nicaragua.
Cuba currently has 87.6% of its population with a complete anti-Covid-19 immunization schedule (9,801,110 people), in addition to 43.2 with the fourth booster injection (4,770,523).